1. Home
  2. FEMY vs AAME Comparison

FEMY vs AAME Comparison

Compare FEMY & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

N/A

Current Price

$0.57

Market Cap

37.2M

Sector

Health Care

ML Signal

N/A

Logo Atlantic American Corporation

AAME

Atlantic American Corporation

N/A

Current Price

$2.70

Market Cap

52.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
FEMY
AAME
Founded
2004
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Life Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
37.2M
52.8M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
FEMY
AAME
Price
$0.57
$2.70
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$5.50
N/A
AVG Volume (30 Days)
407.0K
10.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
0.74%
EPS Growth
8.60
N/A
EPS
N/A
0.22
Revenue
$1,629,108.00
$188,227,000.00
Revenue This Year
$64.02
N/A
Revenue Next Year
$147.19
N/A
P/E Ratio
N/A
$12.23
Revenue Growth
51.97
0.77
52 Week Low
$0.31
$1.25
52 Week High
$1.76
$3.71

Technical Indicators

Market Signals
Indicator
FEMY
AAME
Relative Strength Index (RSI) 54.28 53.39
Support Level $0.54 $2.66
Resistance Level $0.58 $3.16
Average True Range (ATR) 0.03 0.12
MACD 0.01 0.01
Stochastic Oscillator 80.26 44.99

Price Performance

Historical Comparison
FEMY
AAME

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

Share on Social Networks: